The Maine Wire: Congress Should Preserve Public Quality Standards for Biologic Drugs Posted on August 28, 2019 by Liam Sigaud Congress should preserve public quality standards for biologic drugs Further ReadingCoalition Letter Calling on the Senate Not to End the Current Development of Quality Standards for BiologicsCoalition Letter Opposes Price Regulation of Lower Priced Generic DrugsBiologics Are Not A Natural MonopolyBiosimilars: The Grand ExperimentTHE HILL: Public Quality Standards for Biologic Drugs Promote Transparency and Competition; Don’t Get Rid of ThemRegulatory Uncertainty and Industry Practices Force Consumers to Overpay on Biologics
